Monte Rosa Therapeutics Inc (GLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 23,387 | 19,868 | 18,123 | 11,504 | 0 |
| Operating Income | -23,387 | -19,868 | -18,123 | -11,504 | N/A |
| Other Income | -53 | 31 | -282 | -772 | 0 |
| Pre-tax Income | -23,440 | -19,837 | -18,405 | -12,276 | 0 |
| Net Income Continuous | -23,440 | -19,837 | -18,405 | -12,276 | N/A |
| Net Income | $-23,440 | $-19,837 | $-18,405 | $-12,276 | $N/A |
| EPS Basic Total Ops | 8.28 | -0.43 | -3.63 | -7.18 | N/A |
| EPS Basic Continuous Ops | 8.29 | -0.43 | -3.63 | -7.18 | N/A |
| EPS Diluted Total Ops | 8.28 | -0.43 | -3.63 | -7.18 | N/A |
| EPS Diluted Continuous Ops | 8.29 | -0.43 | -3.63 | -7.18 | N/A |
| EBITDA(a) | $-22,578 | $-19,286 | $-17,656 | $-11,230 | $N/A |